[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 30 of about 30
1. Ito K, Mizuguchi Y, Sato A, Kuroda K, Horiguchi A, Kimura F, Sumitomo M, Asano T, Hayakawa M: [Clinical evaluation for adrenal metastasis of renal cell carcinoma in a single institute]. Nihon Hinyokika Gakkai Zasshi; 2008 May;99(4):584-92
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical evaluation for adrenal metastasis of renal cell carcinoma in a single institute].
  • OBJECTIVE: Clinicopathogical features and prognosis of patients with renal cell carcinoma (RCC) concomitant with adrenal involvement (metastasis or invasion) were evaluated in a single institute.
  • METHODS: In 380 patients with RCC who underwent radical nephrectomy 18 patients had adrenal involvement (13 ipsilateral adrenal involvement).
  • RESULTS: Patients with ipsilateral adrenal involvement had significantly higher percentage of tumor>5.5 cm, upper pole tumor, pathological stage (pT) 3< or =, lymph node metastasis, distant metastasis outside ipsilateral adrenal gland, histological grade 3 and microvascular invasion than control patients (p<0.05).
  • Therefore, large tumor (especially 5.5 cm<), upper pole tumor, clinical T3 (especially patients with tumor thrombus), lymph node metastasis and distant metastasis were candidates for risk factors of ipsilateral adrenal involvement.
  • 76.9% of ipsilateral adrenal metastasis could be diagnosed by computed tomography (CT).
  • Thus, preoperative adrenal finding by CT is very important to determine the indication of ipsilateral adrenalectomy.
  • All 3 patients with small ipsilateral adrenal metastasis that could not be detected preoperative CT died within one and half year postoperatively.
  • Patients with solitary adrenal metastasis appeared to have better prognosis compared to those with both adrenal and other metastases.
  • In 4 patients who survived more than 2 years after the presentation of adrenal metastasis, 3 patients had solitary adrenal metastasis and underwent adrenalectomy.
  • CONCLUSION: From the results in a single institute, radiological finding of adrenal grand, tumor size, tumor location, T stage, lymph node metastasis and distant metastasis outside ipsilateral adrenal gland are possible important factors to determine the indication of ipsilateral adrenalectomy preoperatively.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Female. Humans. Kaplan-Meier Estimate. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Prognosis. Risk Factors. Survival Rate. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18536308.001).
  • [ISSN] 0021-5287
  • [Journal-full-title] Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology
  • [ISO-abbreviation] Nippon Hinyokika Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


2. Li D, Mukai K, Suzuki T, Suzuki R, Yamashita S, Mitani F, Suematsu M: Adrenocortical zonation factor 1 is a novel matricellular protein promoting integrin-mediated adhesion of adrenocortical and vascular smooth muscle cells. FEBS J; 2007 May;274(10):2506-22

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, the location of AZ-1 was specified to the basal laminae along adrenocortical sinusoidal capillaries and surrounding VSM cells in the arterial system, consistent with the fact that AZ-1 was extractable under denaturing conditions as a 52 kDa polypeptide.
  • [MeSH-major] Adrenal Cortex / cytology. Carrier Proteins / physiology. Cell Adhesion / physiology. Integrins / physiology. Muscle, Smooth, Vascular / cytology. Neoplasm Proteins / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17425658.001).
  • [ISSN] 1742-464X
  • [Journal-full-title] The FEBS journal
  • [ISO-abbreviation] FEBS J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Carrier Proteins; 0 / Fibronectins; 0 / Integrin alpha1beta1; 0 / Integrin alpha2beta1; 0 / Integrin alpha5beta1; 0 / Integrins; 0 / Lipocalins; 0 / Neoplasm Proteins; 0 / Tinagl protein, mouse; 9007-34-5 / Collagen
  •  go-up   go-down


3. Archontovasilis F, Markogiannakis H, Dikoglou C, Drimousis P, Toutouzas KG, Theodorou D, Katsaragakis S: Paraganglioma of the greater omentum: Case report and review of the literature. World J Surg Oncol; 2007;5:87

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Extra-adrenal, intra-abdominal paraganglioma constitutes a rare neoplasm and, moreover, its location in the greater omentum is extremely infrequent.
  • The tumor was completely excised along with the greater omentum.
  • Histopathology offered the diagnosis of benign greater omentum paraganglioma.
  • Clinical and imaging data of patients with extra-adrenal, intra-abdominal paragangliomas are variable while many of them may be asymptomatic even when the lesion is quite large.
  • Thorough histopathologic evaluation is imperative for diagnosis and radical excision is the treatment of choice.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int Urol Nephrol. 2003;35(4):475-8 [15198147.001]
  • [Cites] Eur Radiol. 2005 Jan;15(1):85-92 [15290072.001]
  • [Cites] Surg Today. 2005;35(7):594-7 [15976959.001]
  • [Cites] Anticancer Res. 2005 May-Jun;25(3c):2449-52 [16080474.001]
  • [Cites] Radiographics. 1991 Jan;11(1):37-57 [1671719.001]
  • [Cites] Endocr Pathol. 2006 Summer;17(2):137-41 [17159246.001]
  • [Cites] Curr Urol Rep. 2007 Jan;8(1):83-8 [17239321.001]
  • [Cites] Hum Pathol. 1990 Nov;21(11):1168-80 [2172151.001]
  • [Cites] AJR Am J Roentgenol. 1990 Dec;155(6):1247-50 [2173385.001]
  • [Cites] Surgery. 1990 Dec;108(6):1124-9; discussion 1129-30 [2174194.001]
  • [Cites] Hum Pathol. 1988 Jan;19(1):41-50 [2447010.001]
  • [Cites] J Chir (Paris). 1989 Apr;126(4):242-7 [2659610.001]
  • [Cites] Arch Pathol Lab Med. 1989 Nov;113(11):1209-18 [2684087.001]
  • [Cites] Surgery. 1985 Dec;98(6):1121-6 [4071388.001]
  • [Cites] Hum Pathol. 1979 Mar;10(2):191-218 [422190.001]
  • [Cites] Arch Surg. 1972 Oct;105(4):637-9 [5071170.001]
  • [Cites] Am J Surg Pathol. 1980 Apr;4(2):109-20 [7377461.001]
  • [Cites] Cancer. 1993 Oct 15;72(8):2358-64 [8402449.001]
  • [Cites] Q J Nucl Med. 1997 Mar;41(1):36-41 [9195851.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):217-8 [10206419.001]
  • [Cites] Mod Pathol. 1999 Dec;12(12):1107-11 [10619262.001]
  • [Cites] Endocrinol Metab Clin North Am. 2000 Mar;29(1):141-57 [10732269.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2000 Dec;8(4):267-74 [11127918.001]
  • [Cites] Mod Pathol. 2003 Mar;16(3):246-55 [12640105.001]
  • [Cites] Eur J Surg Oncol. 2003 Apr;29(3):278-83 [12657240.001]
  • (PMID = 17683569.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1976114
  •  go-up   go-down


Advertisement
4. Kpodonu J, Warso MA, Massad MG: Osteosarcoma invading adrenal gland: rare cause of adrenal mass. Urology; 2005 Jun;65(6):1226
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Osteosarcoma invading adrenal gland: rare cause of adrenal mass.
  • Adrenal gland metastasis from osteogenic sarcoma is extremely rare and is an atypical location for metastasis.
  • Vascular hepatic exclusion techniques and the use of venovenous bypass with cardiac surgical techniques may be required to resect large adrenal masses that have invaded the inferior vena cava to achieve curative resection.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Femoral Neoplasms / pathology. Osteosarcoma / secondary
  • [MeSH-minor] Adult. Humans. Male. Neoplasm Invasiveness. Vena Cava, Inferior / pathology

  • Genetic Alliance. consumer health - Osteosarcoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15922441.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Lopez-Tomassetti Fernandez EM, Luis HD, Malagon AM, Gonzalez IA, Pallares AC: Recurrence of inflammatory pseudotumor in the distal bile duct: lessons learned from a single case and reported cases. World J Gastroenterol; 2006 Jun 28;12(24):3938-43
MedlinePlus Health Information. consumer health - Bile Duct Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Four years after Kaush-Whipple resection, radiological examination on routine follow-up revealed a tumor mass, suggesting local recurrence.
  • Ultrasound-guided FNA confirmed our suspicious diagnosis.
  • This present case, as others, suggests that persistent follow-up is necessary in order to prevent irreversible liver damage at this specific location.
  • [MeSH-major] Bile Duct Neoplasms / pathology. Granuloma, Plasma Cell / pathology. Neoplasm Recurrence, Local / pathology
  • [MeSH-minor] Adrenal Cortex Hormones / therapeutic use. Autoimmune Diseases / classification. Autoimmune Diseases / diagnosis. Autoimmune Diseases / pathology. Female. Humans. Magnetic Resonance Imaging. Middle Aged. Pancreatitis / classification. Pancreatitis / diagnosis. Pancreatitis / pathology. Time Factors. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Rheumatol. 2003 Dec;22(6):467-71 [14677031.001]
  • [Cites] JOP. 2005 Sep;6(5):455-9 [16186668.001]
  • [Cites] Clin Gastroenterol Hepatol. 2003 Nov;1(6):453-64 [15017645.001]
  • [Cites] Am J Surg Pathol. 2004 Sep;28(9):1193-203 [15316319.001]
  • [Cites] Gastroenterology. 2000 Mar;118(3):573-81 [10702209.001]
  • [Cites] N Engl J Med. 2001 Mar 8;344(10):732-8 [11236777.001]
  • [Cites] Thorac Cardiovasc Surg. 2001 Apr;49(2):124-6 [11339451.001]
  • [Cites] Pathol Res Pract. 2001;197(4):237-44 [11358009.001]
  • [Cites] Hepatogastroenterology. 2001 Jul-Aug;48(40):1118-23 [11490814.001]
  • [Cites] J Am Coll Surg. 2002 Apr;194(4):502-6 [11949755.001]
  • [Cites] Pathologe. 2002 Mar;23(2):161-6 [12001534.001]
  • [Cites] Gut. 2003 May;52(5):683-7 [12692053.001]
  • [Cites] Radiology. 2003 Jun;227(3):758-63 [12728186.001]
  • [Cites] Surg Today. 2003;33(9):714-7 [12928854.001]
  • [Cites] J Clin Pathol. 2003 Sep;56(9):715-7 [12944561.001]
  • [Cites] J Gastroenterol. 2003;38(10):982-4 [14614606.001]
  • [Cites] JOP. 2004 Sep;5(5):360-7 [15365204.001]
  • [Cites] Am J Gastroenterol. 2004 Oct;99(10):2038-40 [15447769.001]
  • [Cites] N Engl J Med. 1983 Jan 13;308(2):86-8 [6847938.001]
  • [Cites] South Med J. 1983 May;76(5):647-9 [6844969.001]
  • [Cites] Am J Gastroenterol. 1990 Feb;85(2):203-6 [2405646.001]
  • [Cites] Hum Pathol. 1991 Apr;22(4):387-95 [2050373.001]
  • [Cites] Am J Surg Pathol. 1991 Dec;15(12):1146-56 [1746682.001]
  • [Cites] Arch Pathol Lab Med. 1993 Sep;117(9):921-6 [8368906.001]
  • [Cites] Dig Dis Sci. 1995 Apr;40(4):752-6 [7720466.001]
  • [Cites] Am J Gastroenterol. 1995 Jul;90(7):1155-8 [7611217.001]
  • [Cites] Am J Surg Pathol. 1995 Aug;19(8):859-72 [7611533.001]
  • [Cites] Hum Pathol. 1995 Oct;26(10):1093-8 [7557942.001]
  • [Cites] Ital J Gastroenterol. 1995 Jun;27(5):252-5 [8541577.001]
  • [Cites] Pathology. 1995 Jul;27(3):284-8 [8532398.001]
  • [Cites] Cancer. 1996 Feb 15;77(4):778-84 [8616772.001]
  • [Cites] Am J Surg Pathol. 1996 Jun;20(6):747-53 [8651355.001]
  • [Cites] Cancer. 1995 Nov 1;76(9):1545-9 [8635056.001]
  • [Cites] Hum Pathol. 1996 Oct;27(10):1095-8 [8892598.001]
  • [Cites] Am J Surg Pathol. 1997 Oct;21(10):1166-72 [9331288.001]
  • [Cites] Pancreas. 2005 Nov;31(4):420-3 [16258381.001]
  • [Cites] Endoscopy. 2005 Nov;37(11):1127-30 [16281144.001]
  • [Cites] Pancreatology. 2006;6(1-2):145-54 [16354963.001]
  • [Cites] Pathol Res Pract. 1997;193(7):519-25; discussion 526 [9342759.001]
  • [Cites] Radiology. 1998 Feb;206(2):511-8 [9457206.001]
  • [Cites] Am J Surg Pathol. 1998 Apr;22(4):412-8 [9537467.001]
  • [Cites] Lancet. 1999 Jul 3;354(9172):43-4 [10406367.001]
  • [Cites] AJR Am J Roentgenol. 1999 Oct;173(4):1049-54 [10511176.001]
  • [Cites] Am J Surg Pathol. 2005 Feb;29(2):275-8 [15644785.001]
  • [Cites] JOP. 2005 Jan;6(1 Suppl):97-101 [15650292.001]
  • [Cites] World J Gastroenterol. 2005 Feb 14;11(6):922-5 [15682495.001]
  • [Cites] Histopathology. 2005 Aug;47(2):147-58 [16045775.001]
  • [Cites] Hum Pathol. 2005 Jul;36(7):710-7 [16084938.001]
  • [Cites] Virchows Arch. 2004 Feb;444(2):119-26 [14722765.001]
  • (PMID = 16804988.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones
  • [Number-of-references] 52
  • [Other-IDs] NLM/ PMC4087951
  •  go-up   go-down


6. Chen JH, Yu CY, Pai CY, Chan DC, Chen CJ, Yu JC, Liu YC: Castleman's disease in the left upper retroperitoneal space mimicking an adrenal neoplasm: report of a case and literature review. Jpn J Clin Oncol; 2005 Jun;35(6):353-6
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Castleman's disease in the left upper retroperitoneal space mimicking an adrenal neoplasm: report of a case and literature review.
  • The left suprarenal location of this localized disease may be mistaken for an adrenal tumor.
  • We report a case of a 51-year-old woman with a Castleman's tumor located superomedial to the upper pole of the left kidney that mimicked an adrenal neoplasm.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Giant Lymph Node Hyperplasia / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Middle Aged. Retroperitoneal Space / pathology. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Castleman's Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15928190.001).
  • [ISSN] 0368-2811
  • [Journal-full-title] Japanese journal of clinical oncology
  • [ISO-abbreviation] Jpn. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


7. Russo P, Synder M, Vickers A, Kondagunta V, Motzer R: Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer. ScientificWorldJournal; 2007;7:768-78
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Between July 1989 and September 2003, we queried our department's renal tumor database for patients undergoing cytoreductive nephrectomy alone or in conjunction with complete metastasectomy.
  • Clinical and pathological factors analyzed included primary tumor size, stage and histological subtype, age, gender, Karnofsky Performance Status (KPS) prior to nephrectomy, number and location of metastatic sites, and the presence or absence of any systemic therapy.
  • Sixty-four percent of patients had a single site of metastatic disease, with lung the most common, followed by bone, adrenal, brain, and liver.
  • For patients with metastatic renal cell carcinoma, surgical resection of the primary tumor alone (cytoreductive nephrectomy) or in conjunction with metastasectomy can be accomplished with acceptable perioperative morbidity and mortality.
  • [MeSH-major] Kidney Neoplasms / mortality. Kidney Neoplasms / surgery. Neoplasm Metastasis / prevention & control. Nephrectomy / mortality. Risk Assessment / methods


8. Jurkiewicz D, Niemczyk K, Wojdas A, Kantor I, Jaroń B, Kosek J: [Case of paraganglioma of the originally numerous location in the 24 year old male]. Otolaryngol Pol; 2008;62(2):212-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Case of paraganglioma of the originally numerous location in the 24 year old male].
  • The bening lorms paragangliomas, of the originally numerous location are rare described.
  • MATERIAL AND METHODS: The authors describe the rare case of 24 yrs old male, of the bening form paraganglioma of the originally numerous location - glomus tympanicum on the left site, glomus caroticum on the right site.
  • The diagnosis of a suspected paraganglioma can be confirmed with USG, CT, Angio CT, Angiography and MRI.
  • Radiation therapy may be usefull in those cases in which the residual tumor was known to be left.
  • [MeSH-major] Neoplasms, Multiple Primary / diagnosis. Neoplasms, Multiple Primary / surgery. Paraganglioma, Extra-Adrenal / diagnosis. Paraganglioma, Extra-Adrenal / surgery
  • [MeSH-minor] Adult. Carotid Body Tumor / diagnosis. Carotid Body Tumor / surgery. Glomus Jugulare Tumor / diagnosis. Glomus Jugulare Tumor / surgery. Glomus Tympanicum Tumor / diagnosis. Glomus Tympanicum Tumor / surgery. Humans. Male. Neoplasm Recurrence, Local / surgery. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18637450.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


9. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG: Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. J Urol; 2007 Nov;178(5):1878-82
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
  • To assess and improve the predictive ability of the current pT3a primary tumor classification we evaluated the prognostic significance of location of extrarenal tumor extension on cancer specific survival following surgery.
  • Patients with nonrenal cell carcinoma histology, direct adrenal invasion or a followup of less then 6 months were excluded from analyses.
  • On univariate analyses neither sinus fat invasion nor the location of extrarenal extension, assessed as perinephric fat vs sinus fat vs perinephric plus sinus fat, correlated with cancer specific survival following surgical treatment (HR 1.052, p = 0.783 and HR 1.072, p = 0.543, respectively).
  • After adjusting for the effects of nodal and systemic metastases tumor grade and sarcomatoid differentiation remained independent predictors of renal cell carcinoma specific survival in our pT3a cohort of patients (HR 1.508, p = 0.003 and HR 1.810, p = 0.018, respectively).
  • CONCLUSIONS: In contrast to previously reported observations, in our cohort of surgically treated patients with pT3a renal cell carcinoma the location of extrarenal extension was not an important prognosticator of cancer specific mortality.
  • Based on our findings we confirm that perinephric and/or sinus fat should be similarly subclassified in the primary tumor staging system.
  • [MeSH-minor] Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Nephrectomy / methods. Prognosis. Proportional Hazards Models. Retrospective Studies. Survival Rate / trends. Texas / epidemiology. Time Factors


10. Candanedo-González FA, Vela Chávez T, Cérbulo-Vázquez A: Pleomorphic leiomyosarcoma of the adrenal gland with osteoclast-like giant cells. Endocr Pathol; 2005;16(1):75-81
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pleomorphic leiomyosarcoma of the adrenal gland with osteoclast-like giant cells.
  • Pleomorphic leiomyosarcoma (PLMS) of the adrenal gland is a rare tumor in an unusual location.
  • A primary PLMS of the left adrenal gland is reported in a 59-yr-old Mexican woman who presented progressive flank pain and weight loss.
  • The tumor measured 16 cm in diameter, showed markedly pleomorphic and osteoclast-like giant cells, necrosis, and high mitotic activity (average 15 per 10 high-power fields).
  • DNA content analysis by flow cytometry showed that tumor was diploid, with a high level of apoptosis.
  • Extra-adrenal primary sites of origin were clinically excluded.
  • This is the second case of adrenal PLMS reported.
  • [MeSH-major] Adrenal Gland Neoplasms / pathology. Giant Cells / pathology. Leiomyosarcoma / secondary. Osteoclasts / pathology
  • [MeSH-minor] Apoptosis. Biomarkers, Tumor / analysis. Chemotherapy, Adjuvant. DNA, Neoplasm / analysis. Disease-Free Survival. Female. Humans. Middle Aged. Mitosis. Necrosis. Neoplasm Recurrence, Local. Radiotherapy, Adjuvant

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Surg Oncol. 1981;16(2):145-8 [7464153.001]
  • [Cites] Gynecol Oncol. 1994 Aug;54(2):205-8 [8063247.001]
  • [Cites] Arch Pathol Lab Med. 2003 Jan;127(1):e32-5 [12562292.001]
  • [Cites] Am J Surg Pathol. 2001 Aug;25(8):1030-8 [11474287.001]
  • [Cites] J Histochem Cytochem. 1983 Nov;31(11):1333-5 [6619538.001]
  • [Cites] Int J Urol. 2002 Jan;9(1):54-6 [11972651.001]
  • [Cites] Mod Pathol. 1997 Feb;10(2):91-7 [9127313.001]
  • [Cites] Am J Surg Pathol. 1994 Mar;18(3):258-65 [8116793.001]
  • [Cites] Arch Pathol Lab Med. 1995 Dec;119(12):1164-7 [7503667.001]
  • [Cites] Am J Surg Pathol. 1991 Sep;15(9):899-905 [1951846.001]
  • [Cites] Cancer. 1992 Jul 1;70(1):114-9 [1606532.001]
  • (PMID = 16000850.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / DNA, Neoplasm
  •  go-up   go-down


11. Burel-Vandenbos F, Cardot-Leccia N, Effi B, Varini JP, Saint-Paul MC, Michiels JF: [An unusual tumor of the adrenal gland]. Ann Pathol; 2005 Oct;25(5):386-8
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [An unusual tumor of the adrenal gland].
  • We report the case of a 65-year-old man with an adenomatoid tumor of the adrenal gland.
  • This uncommon location and its histological heterogeneity can lead to a mistaken diagnosis of malignant tumor.
  • Positive cells with mesothelial markers in immunohistochemistry improve diagnosis.
  • The proper identification of this benign tumor in the adrenal gland and the knowledge of its differential diagnosis deserve attention to avoid invasive treatment.
  • [MeSH-major] Adenomatoid Tumor / pathology. Adrenal Gland Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adrenalectomy. Aged. Biomarkers, Tumor / analysis. Diagnosis, Differential. Humans. Lymphangioma / diagnosis. Male. Neoplasm Proteins / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16498291.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  •  go-up   go-down


12. Inzani F, Rindi G, Tamborrino E, Cobelli R, Bordi C: Extra-adrenal composite paraganglioma with ganglioneuroma component presenting as a pancreatic mass. Endocr Pathol; 2009;20(3):191-5
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extra-adrenal composite paraganglioma with ganglioneuroma component presenting as a pancreatic mass.
  • These variants are rare and generally located in the adrenal.
  • Herein, we describe a retroperitoneal, extra-adrenal composite paraganglioma-ganglioneuroma of a 57-year-old woman.
  • Radiological evaluation revealed a nodular mass with apparent pancreatic location, with findings suggestive of an endocrine tumor, yielding the diagnosis of a pancreatic endocrine tumor.
  • At histology the neoplasm, strictly adhering to the external surface of the pancreatic gland but well demarcated, displayed a main central region with typical paraganglioma features and cells arranged in cords and in a nesting "zellballen" pattern, positive for neuroendocrine markers, and a distinct peripheral area consisting of dense bundles of wavy spindled Schwann cells, with scattered ganglionic cells.
  • [MeSH-major] Ganglioneuroma / pathology. Neoplasms, Multiple Primary / pathology. Pancreatic Neoplasms / pathology. Paraganglioma, Extra-Adrenal / pathology
  • [MeSH-minor] Biomarkers, Tumor / analysis. Breast Diseases / complications. Breast Diseases / surgery. Female. Humans. Immunohistochemistry. Leiomyoma / complications. Leiomyoma / surgery. Middle Aged. Tomography, X-Ray Computed. Uterine Neoplasms / complications. Uterine Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Semin Diagn Pathol. 2000 May;17(2):120-6 [10839612.001]
  • [Cites] J Histochem Cytochem. 1984 Aug;32(8):899-904 [6146648.001]
  • [Cites] J Clin Endocrinol Metab. 1987 Nov;65(5):1053-6 [3667875.001]
  • [Cites] Arch Pathol Lab Med. 1988 Mar;112(3):266-70 [2894207.001]
  • [Cites] Saudi Med J. 2006 Oct;27(10 ):1594-7 [17013491.001]
  • [Cites] Pathol Res Pract. 1992 Dec;188(8):1098-100; discussion 1101-3 [1300605.001]
  • [Cites] Endocr Pathol. 1999 Winter;10(4):343-352 [12114771.001]
  • [Cites] Hum Pathol. 1990 Nov;21(11):1168-80 [2172151.001]
  • [Cites] Surgery. 1990 Dec;108(6):1124-9; discussion 1129-30 [2174194.001]
  • [Cites] Am J Surg Pathol. 1993 Aug;17(8):837-41 [8338194.001]
  • [Cites] Am J Surg Pathol. 1997 Jan;21(1):102-8 [8990146.001]
  • [Cites] Endocr Pathol. 1998 Winter;9(1):353-361 [12114785.001]
  • (PMID = 19598001.001).
  • [ISSN] 1559-0097
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


13. Alamdari FI, Ljungberg B: Adrenal metastasis in renal cell carcinoma: a recommendation for adjustment of the TNM staging system. Scand J Urol Nephrol; 2005;39(4):277-82
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adrenal metastasis in renal cell carcinoma: a recommendation for adjustment of the TNM staging system.
  • OBJECTIVES: To study the incidence of adrenal metastasis in patients with renal cell carcinoma (RCC) of all stages, its correlation with clinicopathological variables and its impact on survival.
  • The accuracy of the available preoperative radiological examinations was evaluated and any adrenal involvement was compared with other clinical and histopathological findings.
  • RESULTS: Ipsilateral adrenal tumour involvement was detected in 17/321 patients (5.3%).
  • In four of these patients, the adrenal gland was the only preoperatively found metastatic site.
  • Factors predicting the presence of ipsilateral adrenal metastases were male gender, tumour size, vein invasion, renal capsule and perirenal fat invasion.
  • Tumour location within the kidney and tumour side had no predictive value for the presence of adrenal metastasis.
  • The presence of ipsilateral adrenal involvement was a significant adverse prognostic variable, indicating a short survival time (p<0.001).
  • CONCLUSIONS: Ipsilateral adrenal metastasis is a highly adverse prognostic factor.
  • In the TNM staging system, adrenal gland involvement should be staged as M1a.
  • Ipsilateral adrenalectomy in conjunction with radical nephrectomy should be performed if an adrenal lesion cannot be cleared of suspicion after preoperative radiological imaging, as in locally advanced tumours.
  • The adrenal gland can be left in situ if the ipsilateral adrenal gland is assessed as normal at the preoperative investigation and perioperatively by the surgeon.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology
  • [MeSH-minor] Adrenalectomy. Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Staging. Nephrectomy. Survival Analysis

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16118103.001).
  • [ISSN] 0036-5599
  • [Journal-full-title] Scandinavian journal of urology and nephrology
  • [ISO-abbreviation] Scand. J. Urol. Nephrol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Sweden
  •  go-up   go-down


14. O'Malley RL, Godoy G, Kanofsky JA, Taneja SS: The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review. J Urol; 2009 May;181(5):2009-17
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: We describe the literature base pertaining to adrenalectomy at radical nephrectomy and present a pragmatic approach based on primary tumor and disease characteristics.
  • RESULTS: The incidence of solitary, synchronous, ipsilateral adrenal involvement, ie that which is potentially curable with ipsilateral adrenalectomy along with nephrectomy, is much lower than previously thought at 1% to 5%.
  • Evidence to date supports increased size and T stage, multifocality, upper pole location and venous thrombosis as risk factors for adrenal involvement.
  • Cross-sectional imaging is now accurate at demonstrating the absence of adrenal involvement but still carries a significant risk of false-positives.
  • The morbidity of adrenalectomy is minimal except in those patients with metachronous contralateral adrenal metastasis in whom the impact of adrenal insufficiency can be devastating.
  • There is evidence for a survival advantage in patients with isolated adrenal metastasis, although this group comprises no more than 2% of those undergoing surgery for renal tumors.
  • However, it should be considered in select cases in which there are risk factors for adrenal involvement.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Adrenal Gland Neoplasms / surgery. Carcinoma, Renal Cell / secondary. Carcinoma, Renal Cell / surgery. Kidney Neoplasms / surgery. Neoplasm Recurrence, Local / mortality
  • [MeSH-minor] Adrenalectomy / methods. Combined Modality Therapy. Diagnostic Imaging / methods. Female. Humans. Lymphatic Metastasis. Male. Neoplasm Staging. Nephrectomy / methods. Prognosis. Retrospective Studies. Risk Assessment. Survival Analysis. Time Factors

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19286216.001).
  • [ISSN] 1527-3792
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 56
  •  go-up   go-down


15. Pagni F, Galbiati E, Bono F, Di Bella C: Renal hilus paraganglioma: a case report and brief review. Pathologica; 2009 Apr;101(2):89-92
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Among extra-adrenal paraganglioma, renal hilus is a rare location.
  • Histological study revealed a neoplasm constituted of nests of monomorphic cuboidal cells with basophilic granular cytoplasm and round to oval nuclei.
  • The final diagnosis was renal hilus paraganglioma.
  • [MeSH-major] Kidney Neoplasms / pathology. Paraganglioma, Extra-Adrenal / pathology
  • [MeSH-minor] Adult. Carcinoma, Renal Cell / pathology. Carcinoma, Transitional Cell / pathology. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Nephrectomy. Pelvic Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19886555.001).
  • [ISSN] 0031-2983
  • [Journal-full-title] Pathologica
  • [ISO-abbreviation] Pathologica
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


16. Valsamis A, Oliverius M, Varga M, Mares K: [Primary retroperitoneal tumor--extraadrenal paraganglioma--a case review]. Rozhl Chir; 2008 May;87(5):263-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary retroperitoneal tumor--extraadrenal paraganglioma--a case review].
  • [Transliterated title] Primární retroperitoneální tumor--extraadrenální paragangliom--kazuistika.
  • Primary retroperitoneal tumors are extremely rare tumors of this location.
  • The authors present a case review of a 53-year-old patient operated for unexplained retroperitoneal neoplasm.
  • Preoperative hypertension subsided postoperatively, following the active neuroendocrinne tumor removal.
  • The aim of this work is to present clinical and histopathological characteristics of this rare retroperitoenal neoplasm.
  • [MeSH-major] Paraganglioma, Extra-Adrenal / pathology. Retroperitoneal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18595545.001).
  • [ISSN] 0035-9351
  • [Journal-full-title] Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti
  • [ISO-abbreviation] Rozhl Chir
  • [Language] cze
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


17. Sagan D, Zdunek M, Korobowicz E: Primary myelolipoma of the chest wall. Ann Thorac Surg; 2009 Oct;88(4):e39-41
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Myelolipoma is a rare neoplasm composed of an admixture of mature adipose tissue and hematopoietic elements.
  • It typically occurs in adrenal glands as a solitary, well-circumscribed mass, and the thoracic location is extremely unusual.
  • We present a 63-year-old man with an accidentally detected tumor of the chest wall.
  • Thoracoscopic resection and subsequent histopathologic examination of the lesion revealed myelolipoma with bony spicules, which are an unusual component in this neoplasm.
  • We discuss the etiology, histopathology, differential diagnosis, and recommended management of extra-adrenal myelolipoma, and we conclude that it should be considered in the differential diagnosis of subpleural chest wall tumors.
  • [MeSH-major] Lung Neoplasms / diagnosis. Myelolipoma / diagnosis. Pneumonectomy / methods
  • [MeSH-minor] Diagnosis, Differential. Follow-Up Studies. Humans. Male. Middle Aged. Thoracoscopy. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19766776.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


18. Amo Trillo V, Vera García P, Pinto I, Olmedo Martín R, Romero Blasco B: [Extramedullary plasmacytoma of the colon]. Gastroenterol Hepatol; 2007 May;30(5):277-9
Hazardous Substances Data Bank. MELPHALAN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • No other location was affected (including bone marrow).
  • Diagnosis of plasmacytoma of the colon was made.
  • [MeSH-major] Plasmacytoma / diagnosis. Sigmoid Neoplasms / diagnosis
  • [MeSH-minor] Adrenal Cortex Hormones / administration & dosage. Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Colonoscopy. Combined Modality Therapy. Diverticulum / complications. Fatal Outcome. Gastrointestinal Hemorrhage / etiology. Hemorrhoids / complications. Humans. Lymphatic Metastasis. Male. Melphalan / administration & dosage. Neoplasm Recurrence, Local / drug therapy. Rectum

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17493438.001).
  • [ISSN] 0210-5705
  • [Journal-full-title] Gastroenterología y hepatología
  • [ISO-abbreviation] Gastroenterol Hepatol
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones; Q41OR9510P / Melphalan
  •  go-up   go-down


19. Quackenbush KE, Luna-Fineman S, Magee JF, Gundogan M, Golobi M, Irie T, Fernandez CV: Neuroblastoma involvement of the falx cerebri. Pediatr Blood Cancer; 2009 Dec 15;53(7):1337-9
Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The falx is derived from the neural crest and thus may be a location for primary neuroblastoma.
  • Management of neuroblastoma in this location is potentially challenging.
  • [MeSH-major] Adrenal Gland Neoplasms / pathology. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Dura Mater / pathology. Meningeal Neoplasms / secondary. Neuroblastoma / secondary
  • [MeSH-minor] Adrenalectomy. Carboplatin / administration & dosage. Cell Lineage. Cyclophosphamide / administration & dosage. Doxorubicin / administration & dosage. Etoposide / administration & dosage. Female. Humans. Infant. Infant, Newborn. Male. Microphthalmia-Associated Transcription Factor / genetics. Neoplasm Staging. Neural Crest. Pulmonary Veins / abnormalities. Remission Induction. Skin Neoplasms / drug therapy. Skin Neoplasms / secondary. Waardenburg Syndrome / complications. Waardenburg Syndrome / genetics

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2009 Wiley-Liss, Inc.
  • (PMID = 19821537.001).
  • [ISSN] 1545-5017
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / MITF protein, human; 0 / Microphthalmia-Associated Transcription Factor; 6PLQ3CP4P3 / Etoposide; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; BG3F62OND5 / Carboplatin
  •  go-up   go-down


20. Brankov O, Drebov R, Stoilov S, Panov M, Penushliev T, Georgiev Ts: [Malignant neurogenic tumors with retroperitoneal and mediastinal locations in infants]. Khirurgiia (Sofiia); 2007;(1-2):5-8
MedlinePlus Health Information. consumer health - Neuroblastoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Age and sex of the children, the frequency of location, maturity and stage of the tumor, type of operations and survival rate are compared.
  • Most of them have an unfavorable histological variant and affect predominantly the adrenal glands.
  • [MeSH-minor] Child, Preschool. Disease-Free Survival. Female. Humans. Infant. Male. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18461028.001).
  • [ISSN] 0450-2167
  • [Journal-full-title] Khirurgii︠a︡
  • [ISO-abbreviation] Khirurgiia (Sofiia)
  • [Language] bul
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Bulgaria
  •  go-up   go-down


21. Grever MR, Lucas DM, Johnson AJ, Byrd JC: Novel agents and strategies for treatment of p53-defective chronic lymphocytic leukemia. Best Pract Res Clin Haematol; 2007 Sep;20(3):545-56
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Over-represented in this group are those who have a deletion of 17p13.1, the chromosomal location of the tumor suppressor gene P53.
  • [MeSH-major] Leukemia, Lymphocytic, Chronic, B-Cell / therapy. Tumor Suppressor Protein p53 / deficiency
  • [MeSH-minor] Adrenal Cortex Hormones / therapeutic use. Antibodies, Monoclonal / therapeutic use. Antibodies, Monoclonal, Humanized. Antibodies, Neoplasm / therapeutic use. Apoptosis / drug effects. CD40 Ligand / therapeutic use. Chromosomes, Human, Pair 17. Combined Modality Therapy. Flavonoids / therapeutic use. Gene Deletion. Humans. Middle Aged. Piperidines / therapeutic use

  • Genetic Alliance. consumer health - Chronic Lymphocytic Leukemia.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17707839.001).
  • [ISSN] 1521-6926
  • [Journal-full-title] Best practice & research. Clinical haematology
  • [ISO-abbreviation] Best Pract Res Clin Haematol
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01 CA81534-02
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Antibodies, Neoplasm; 0 / Flavonoids; 0 / Piperidines; 0 / Tumor Suppressor Protein p53; 147205-72-9 / CD40 Ligand; 3A189DH42V / alemtuzumab; 45AD6X575G / alvocidib
  •  go-up   go-down


22. Querellou S, Keromnes N, Abgral R, Sassolas B, Le Roux PY, Cavarec MB, Le Duc-Pennec A, Couturier O, Salaun PY: Clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanoma. Nucl Med Commun; 2010 Sep;31(9):766-72
MedlinePlus Health Information. consumer health - Melanoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PET/CT abnormalities on the lower extremities were tabulated by location and correlated with pathology, other imaging studies and at least a 6-month clinical follow-up.
  • In 28 cases, uptakes were located at once in the lower limbs and in the rest of the body (lung, liver, mediastinal and sub-diaphragmatic lymph nodes, adrenal glands, bone) corresponding to disseminated disease.
  • [MeSH-major] Fluorodeoxyglucose F18. Lower Extremity / radiography. Lower Extremity / radionuclide imaging. Melanoma / diagnosis. Positron-Emission Tomography / methods. Tomography, X-Ray Computed / methods. Whole Body Imaging / methods
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Staging. Retrospective Studies

  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Nucl Med Commun. 2011 Jun;32(6):544-5 [21505291.001]
  • (PMID = 20585271.001).
  • [ISSN] 1473-5628
  • [Journal-full-title] Nuclear medicine communications
  • [ISO-abbreviation] Nucl Med Commun
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


23. Ludvigsen L, Toxvaerd A, Mahdi B, Krarup-Hansen A, Bergenfeldt M: Successful resection of an advanced duodenal gastrointestinal stromal tumor after down-staging with imatinib: report of a case. Surg Today; 2007;37(12):1105-9
Hazardous Substances Data Bank. IMATINIB MESYLATE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful resection of an advanced duodenal gastrointestinal stromal tumor after down-staging with imatinib: report of a case.
  • The diagnosis of gastrointestinal stromal tumor (GIST) relies on a combination of the following criteria: anatomic location, typical histopathology, and the presence of CD 117-antigen (the tyrosine kinase receptor, c-kit) or CD 34-antigen.
  • We performed Whipple's procedure combined with en bloc resection of the right kidney and adrenal gland.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Duodenal Neoplasms / surgery. Gastrointestinal Stromal Tumors / surgery. Neoplasm Recurrence, Local / surgery. Pancreaticoduodenectomy / methods. Piperazines / therapeutic use. Pyrimidines / therapeutic use
  • [MeSH-minor] Adult. Benzamides. Diagnosis, Differential. Dose-Response Relationship, Drug. Follow-Up Studies. Humans. Imatinib Mesylate. Male. Neoplasm Staging. Positron-Emission Tomography. Protein-Tyrosine Kinases / antagonists & inhibitors. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg. 2000 Jan;231(1):51-8 [10636102.001]
  • [Cites] Surgery. 2003 Oct;134(4):656-65; discussion 665-6 [14605627.001]
  • [Cites] Curr Oncol Rep. 2005 Jul;7(4):307-11 [15946591.001]
  • [Cites] Am J Surg. 2003 Dec;186(6):665-9 [14672776.001]
  • [Cites] Am J Surg Pathol. 1983 Sep;7(6):507-19 [6625048.001]
  • [Cites] N Engl J Med. 2001 Apr 5;344(14):1052-6 [11287975.001]
  • [Cites] J Clin Oncol. 2005 Aug 20;23(24):5795-804 [16110036.001]
  • [Cites] N Engl J Med. 2002 Aug 15;347(7):472-80 [12181401.001]
  • [Cites] Hum Pathol. 2002 May;33(5):459-65 [12094370.001]
  • [Cites] Lancet. 2004 Sep 25-Oct 1;364(9440):1127-34 [15451219.001]
  • [Cites] Am J Pathol. 1998 May;152(5):1259-69 [9588894.001]
  • [Cites] Science. 1998 Jan 23;279(5350):577-80 [9438854.001]
  • [Cites] Dis Colon Rectum. 2005 Jun;48(6):1316-9 [15793646.001]
  • [Cites] Gastrointest Endosc. 2005 Apr;61(4):625-7 [15812427.001]
  • [Cites] Anticancer Drugs. 2004 Jul;15(6):599-602 [15205603.001]
  • [Cites] Br J Cancer. 2003 Aug 4;89(3):460-4 [12888812.001]
  • [Cites] Ann Oncol. 2005 Apr;16(4):566-78 [15781488.001]
  • [Cites] Ann Surg. 1987 Dec;206(6):706-10 [3689007.001]
  • [Cites] Mod Pathol. 2003 Apr;16(4):366-75 [12692202.001]
  • [Cites] Am J Surg Pathol. 1999 Jan;23(1):82-7 [9888707.001]
  • [Cites] Cancer Res. 2001 Nov 15;61(22):8118-21 [11719439.001]
  • [Cites] Ann Surg Oncol. 2004 May;11(5):465-75 [15123459.001]
  • [Cites] Ann Surg. 1992 Jan;215(1):68-77 [1731651.001]
  • (PMID = 18030576.001).
  • [ISSN] 0941-1291
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate; EC 2.7.10.1 / Protein-Tyrosine Kinases
  •  go-up   go-down


24. Vogl TJ, Zangos S, Eichler K, Balzer JO, Jacob U, Keilhauer R, Bauer RW: [Transarterial chemoperfusion of the pelvis--results in symptomatic locally recurrent tumors and lymph node metastases]. Rofo; 2007 Nov;179(11):1174-80
Hazardous Substances Data Bank. MITOMYCIN C .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To evaluate local transarterial chemoperfusion (TACP) of therapy-resistant, locally recurrent malignant tumors and lymph node metastases in the pelvis with respect to clinical response, tumor response and survival.
  • Depending on the tumor location and vascularization, a fluoroscopy catheter was placed either in the abdominal aorta or internal pelvic artery.
  • The tumor size was measured using CT or MRI.
  • In the case of clinical and radiological progression, therapy was stopped and the patient was referred to the hospital's tumor board.
  • Tumor-related pain, bleeding, restricted mobility of the lower extremities, incontinence, urinary tract obstruction, and constipation were reduced in 9/17, 5/6, 3/3, 1/3, 2/5, and 1/3 of cases (clinical response rate: 54%).
  • Radiologically, 4/24 (17%) patients showed PR, 12/24 (50%) SD, and 8/24 (34%) PD (tumor control (PR+SD): 67% of cases).
  • Tumor response (median survival since first TACP) was as follows: colorectal: 2 PR, 7 SD, 2 PD (11.5 months), ovarian: 1 SD, 2 PD (8.5 mon), cervical: 1 PR, 1 SD (6 mon), breast: 2 SD (6 mon), gastric: 1 PD (11 mon), adrenal gland: 1 PD (12 mon), anal: 1 PD (10 mon), prostate: 1 PD (20 mon), Gartner's duct: 1 PR (20 mon), renal cell carcinoma: 1 SD (10 mon).
  • CONCLUSION: Since tumor-related complaints were improved in 54% of the cases and control of tumor growth (PR+SD) was achieved in 67% of the cases, TACP for recurrent pelvic malignancies should be considered as a palliative oncological treatment option.
  • [MeSH-major] Lymphatic Metastasis / pathology. Neoplasm Recurrence, Local / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antineoplastic Agents / administration & dosage. Antineoplastic Agents / therapeutic use. Arteries. Drug Resistance, Neoplasm. Female. Humans. Injections, Intra-Arterial / adverse effects. Middle Aged. Mitomycin / administration & dosage. Mitomycin / therapeutic use. Perfusion / adverse effects. Retrospective Studies. Survival Analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17805998.001).
  • [ISSN] 1438-9029
  • [Journal-full-title] RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin
  • [ISO-abbreviation] Rofo
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 50SG953SK6 / Mitomycin
  •  go-up   go-down


25. Moon SB, Park KW, Jung SE, Youn WJ: Neuroblastoma: treatment outcome after incomplete resection of primary tumors. Pediatr Surg Int; 2009 Sep;25(9):789-93
Hazardous Substances Data Bank. 13-CIS-RETINOIC ACID .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: For International Neuroblastoma Staging System (INSS) stages III or IV neuroblastoma (intermediate or high risk), complete excision of the primary tumor is not always feasible.
  • Age, gender, tumor location, INSS stage, N-myc gene copy number, pre- and postoperative therapy, and treatment outcome were reviewed.
  • [MeSH-minor] Adrenal Gland Neoplasms / mortality. Adrenal Gland Neoplasms / pathology. Adrenal Gland Neoplasms / therapy. Antineoplastic Agents / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Child. Child, Preschool. Dermatologic Agents / therapeutic use. Female. Follow-Up Studies. Genes, myc. Humans. Infant. Interleukin-2 / therapeutic use. Isotretinoin / therapeutic use. Male. Mediastinal Neoplasms / mortality. Mediastinal Neoplasms / pathology. Mediastinal Neoplasms / therapy. Neoplasm, Residual. Pelvic Neoplasms / mortality. Pelvic Neoplasms / pathology. Pelvic Neoplasms / therapy. Peripheral Blood Stem Cell Transplantation. Radiotherapy, Adjuvant. Retroperitoneal Neoplasms / mortality. Retroperitoneal Neoplasms / pathology. Retroperitoneal Neoplasms / therapy. Retrospective Studies

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 1998 Apr;16(4):1256-64 [9552023.001]
  • [Cites] J Clin Oncol. 2009 Mar 1;27(7):1007-13 [19171716.001]
  • [Cites] Semin Surg Oncol. 1993 Nov-Dec;9(6):489-92 [8284567.001]
  • [Cites] J Clin Oncol. 2006 Jun 20;24(18):2891-6 [16782928.001]
  • [Cites] J Neuroimmunol. 1999 May 3;96(2):201-6 [10337918.001]
  • [Cites] Blood. 1998 Mar 1;91(5):1706-15 [9473237.001]
  • [Cites] J Clin Oncol. 1998 Mar;16(3):953-65 [9508178.001]
  • [Cites] J Pediatr Surg. 2002 Nov;37(11):1574-8 [12407542.001]
  • [Cites] Cancer Lett. 2003 Jul 18;197(1-2):185-92 [12880980.001]
  • [Cites] J Pediatr Surg. 2004 Mar;39(3):412-7; discussion 412-7 [15017562.001]
  • [Cites] Eur J Cancer. 1997 Oct;33(12):2024-30 [9516847.001]
  • [Cites] J Korean Med Sci. 2003 Apr;18(2):242-7 [12692423.001]
  • [Cites] J Clin Oncol. 1996 Sep;14(9):2417-26 [8823319.001]
  • [Cites] N Engl J Med. 1999 Oct 14;341(16):1165-73 [10519894.001]
  • [Cites] J Hematother. 1997 Jun;6(3):235-42 [9234178.001]
  • [Cites] J Pediatr Surg. 2004 Jun;39(6):931-6 [15185228.001]
  • [Cites] Bone Marrow Transplant. 1999 Jan;23 (2):169-72 [10197803.001]
  • (PMID = 19629500.001).
  • [ISSN] 1437-9813
  • [Journal-full-title] Pediatric surgery international
  • [ISO-abbreviation] Pediatr. Surg. Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Dermatologic Agents; 0 / Interleukin-2; EH28UP18IF / Isotretinoin
  •  go-up   go-down


26. Kuroda N, Hamauzu T, Toi M, Yamaoka K, Miyazaki E, Hiroi M, Nakata H, Taguchi H, Enzan H: Pulmonary adenocarcinoma with micropapillary component: an immunohistochemical study. Case report. APMIS; 2005 Jul-Aug;113(7-8):550-4
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The tumor showed moderately differentiated papillary adenocarcinoma with a focal micropapillary component.
  • Carcinomatous lymphangiosis was also observed in the left lung and metastatic lesions were observed in the bilateral lung, liver, vertebra, muscle layer of the urinary bladder, right adrenal gland, spleen and lymph nodes.
  • The immunohistochemical profile may be helpful in determining the primary location of the neoplasm containing micropapillary features.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16086826.001).
  • [ISSN] 0903-4641
  • [Journal-full-title] APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
  • [ISO-abbreviation] APMIS
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Carcinoembryonic Antigen; 0 / KRT7 protein, human; 0 / Keratin-7; 0 / Nuclear Proteins; 0 / Pulmonary Surfactant-Associated Protein A; 0 / Transcription Factors; 0 / thyroid nuclear factor 1; 68238-35-7 / Keratins
  •  go-up   go-down


27. Adamiak A, Lee CH, Nielsen TO, Webber D, O'Connell JX: Duodenal epithelioid gastrointestinal stromal tumor with prominent granular cell features. Hum Pathol; 2009 Apr;40(4):599-602
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Duodenal epithelioid gastrointestinal stromal tumor with prominent granular cell features.
  • We report a case of duodenal gastrointestinal stromal tumor with a highly unusual epithelioid morphology that had an appearance reminiscent of a steroid producing neoplasm, such as an adrenal cortical neoplasm or, alternatively, a renal cell carcinoma variant.
  • The recognition of the current tumor as a duodenal gastrointestinal stromal tumor was prompted by its apparent location in the duodenal wall.
  • Ancillary immunohistochemical and molecular sequence analyses were necessary to confirm the diagnosis as a gastrointestinal stromal tumor.
  • The current case illustrates the importance of considering gastrointestinal stromal tumor in the differential diagnosis of any epithelioid tumors in the gastrointestinal tract or the abdominal-pelvic cavity.
  • [MeSH-minor] Adenoma / pathology. Biomarkers, Tumor / analysis. Duodenal Ulcer / complications. Humans. Immunohistochemistry. Male. Middle Aged. Mutation. Neoplasms, Multiple Primary / pathology. Pituitary Neoplasms / pathology. Proto-Oncogene Proteins c-kit / genetics

  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19121840.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


28. Gong Y, Ren R, Ordóñez NG, Sun X, Sneige N: Fine needle aspiration cytology of well-differentiated papillary mesothelioma: a case report. Acta Cytol; 2005 Sep-Oct;49(5):537-42
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fine needle aspiration (FNA) of this type of tumor has rarely been reported.
  • CASE: A 64-year-old woman with 11-year history of colon cancer and an adrenal nodule was found, on abdominal computed tomography, to have a mass in the right lobe of the liver.
  • Tumor cells in the focal tubulopapillary and solid areas were mingled with inflammatory cells and showed slightly more atypia than did the cells covering the papillae.
  • The differential diagnoses were intrahepatic papillary neoplasm, including well-differentiated mesothelioma and metastatic low grade papillary serous carcinoma.
  • At surgery the tumor was found to be a pedunculated peritoneal mass that arose from the posterior surface of the right lobe of the liver.
  • The mesothelial origin of the tumor was confirmed by both immunoperoxidase study and electron microscopic examination, which demonstrated long, slender, branching microvilli.
  • CONCLUSION: Familiarity with the cytomorphologic features and clinical presentation of WDPM, knowledge of the exact anatomic location and consideration of the appropriate differential diagnosis combined with ancillary studies are the keys to an accurate diagnosis.
  • [MeSH-minor] Biopsy, Fine-Needle. Carcinoma / pathology. Carcinoma / radiography. Diagnosis, Differential. Diagnostic Errors / prevention & control. Epithelial Cells / pathology. Epithelial Cells / ultrastructure. Epithelium / pathology. Epithelium / ultrastructure. Female. Humans. Liver / pathology. Microscopy, Electron, Transmission. Middle Aged. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Mesothelioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16334033.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Fandella A, Borghesi M, Bertaccini A: Renal cell carcinoma. 2002 TNM classification is still adequate? Arch Ital Urol Androl; 2009 Mar;81(1):51-5
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Really it doesn't make a distinction when performed a conservative therapy in the early stages: literature and the clinical experience suggest that the criteria for a partial resection of the kidney is the location of the tumour, rather than its size; for this reason, the division pT1 a-pT1b is rather outdated.
  • Moreover, the T2 category, isto-pathologically restricted, receives less than 2% of all kidney cancers; into the T3 category, if there is also adrenal invasion, it makes a worse prognostic trend, similar to T4 category.

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19499760.001).
  • [ISSN] 1124-3562
  • [Journal-full-title] Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
  • [ISO-abbreviation] Arch Ital Urol Androl
  • [Language] ENG
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 41
  •  go-up   go-down


30. Witte B, Neumeister W, Huertgen M: Does endoesophageal ultrasound-guided fine-needle aspiration replace mediastinoscopy in mediastinal staging of thoracic malignancies? Eur J Cardiothorac Surg; 2008 Jun;33(6):1124-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: One hundred and twenty patients, aged 64.1 years (range 38-85) underwent 120 EUS-FNA, 53 video-assisted mediastinoscopic and 48 open lymphadenectomies for diagnosis and treatment of 99 lung carcinoma, six lung metastases, five mesothelioma, three lymphoma, and eight other conditions.
  • EUS-FNA showed T4 in 15/120 and adrenal or hepatic metastases in 9/120 cases.
  • CONCLUSIONS: EUS-FNA sensitivity depends on the localisation of the primary tumour, and extent and location of mediastinal disease.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Endosonography / methods. False Negative Reactions. Female. Humans. Lung Neoplasms / pathology. Lung Neoplasms / ultrasonography. Lymph Node Excision. Lymphatic Metastasis. Male. Mediastinoscopy. Middle Aged. Neoplasm Staging. Prospective Studies. Sensitivity and Specificity

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18430581.001).
  • [ISSN] 1010-7940
  • [Journal-full-title] European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • [ISO-abbreviation] Eur J Cardiothorac Surg
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down






Advertisement